Your browser doesn't support javascript.
loading
Analysis of the AIRE Gene Promoter in Patients Affected by Autoimmune Polyendocrine Syndromes.
Cudini, Annamaria; Nardella, Caterina; Bellacchio, Emanuele; Palma, Alessia; Delfino, Domenico Vittorio; Betterle, Corrado; Cappa, Marco; Fierabracci, Alessandra.
Afiliação
  • Cudini A; Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
  • Nardella C; Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
  • Bellacchio E; Molecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
  • Palma A; Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
  • Delfino DV; Section of Pharmacology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.
  • Betterle C; Padua University, 35128 Padua, Italy.
  • Cappa M; Research Unit for Innovative Therapies in Endocrinopathies, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
  • Fierabracci A; Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Int J Mol Sci ; 25(5)2024 Feb 24.
Article em En | MEDLINE | ID: mdl-38473903
ABSTRACT
Autoimmune polyglandular syndromes (APS) are classified into four main categories, APS1-APS4. APS1 is caused by AIRE gene loss of function mutations, while the genetic background of the other APS remains to be clarified. Here, we investigated the potential association between AIRE gene promoter Single Nucleotide Polymorphisms (SNPs) and susceptibility to APS. We sequenced the AIRE gene promoter of 74 APS patients, also analyzing their clinical and autoantibody profile, and we further conducted molecular modeling studies on the identified SNPs. Overall, we found 6 SNPs (-230Y, -655R, -261M, -380S, -191M, -402S) of the AIRE promoter in patients' DNA. Interestingly, folding free energy calculations highlighted that all identified SNPs, except for -261M, modify the stability of the nucleic acid structure. A rather similar percentage of APS3 and APS4 patients had polymorphisms in the AIRE promoter. Conversely, there was no association between APS2 and AIRE promoter polymorphisms. Further AIRE promoter SNPs were found in 4 out of 5 patients with APS1 clinical diagnosis that did not harbor AIRE loss of function mutations. We hypothesize that AIRE promoter polymorphisms could contribute to APS predisposition, although this should be validated through genetic screening in larger patient cohorts and in vitro and in vivo functional studies.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Poliendocrinopatias Autoimunes Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Poliendocrinopatias Autoimunes Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália